(-)-Menthol inhibits DNA topoisomerases I, II α and β and promotes NF-κB expression in human gastric cancer SNU-5 cells

Anticancer Research

Volumn 25, Issue 3 B, 2005, Pages 2069-2074

  Lin, Jing Pin ^a   Lu, Hsu Feng ^c   Lee, Jau Hong ^b   Lin, Jaung Gung ^a   Hsia, Te Chun ^b   Wu, Lii Tzu ^a   Chung, Jing Gung ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

Author keywords

( ) Menthol; DNA topoisomerase I; Gastric cancer; Topoisomerase II ; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MENTHOL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DEATH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER TUMOR; PRIORITY JOURNAL; STOMACH CANCER;

ANTIGENS, NEOPLASM; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DNA DAMAGE; DNA TOPOISOMERASES; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; MENTHOL; NF-KAPPA B; STEREOISOMERISM; STOMACH NEOPLASMS;

EID: 21344443439     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Macfoy CA and Cline EI: In vitro antibacterial activities of three plants used in traditional medicine in Sierra Leone. J Ethnopharmacol 28: 323-327, 1990.
2. Pattnik S, Subramanyan VR, Bapaji M and Kole CR: Antibacterial and antifungal activity of aromatic constituents. Microbios 89: 39-46, 1997.
3. Rudo K, Meyers WC, Dauterman W and Langenbach R: Comparison of human and rat hepatocytes metabolism and mutagenic activation of 2-acetylaminofluorene. Cancer Res 47: 5861-5867, 1987.
4. Russin WW, Hoesly JD, Elson CE, Tanner MA and Gould MN: Inhibition of rat mammary carcinogenesis by monoterpenoids. Carcinogenesis 10: 2161-2164, 1989.
5. Lin JP, Li YC, Lin WC, Hsieh CL and Chung JG: Effects of (-)-Menthol on arylamine N-acetyltransferase activity in human liver tumor cells. Am J Chinese Med 29: 321-329, 2001.
6. Lin JP, Chen KC, Chen GW, Yang MD, Chiu TH and Chung JG: Effects of (-)-Menthol on the distribution and metabolism of 2-aminofluorene in various tissues of Sprague-Dawley rats. In Vivo 7: 441-456, 2003.
7. Chung JG: Effects of garlic components diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in human bladder tumour cells. Drug Chem Toxicol 22: 343-358, 1999.
8. Ganapathi R, Vaziri SA, Tabata M, Takigawa N, Grabowski DR, Bukowski RM and Ganapathi MK: Inhibition of NF-kappaB and proteasome activity in tumors: can we improve the therapeutic potential of topoisomerase I and topoisomerase II poisons. Curr Pharm Des 8: 1945-1958, 2002.
9. Arimondo PB and Helene C: Design of new anti-cancer agents based on topoisomerase poisons targeted to specific DNA sequences. Curr Med Chem Anti-Cancer Agents 1: 219-35, 2001.
10. Barret JM, Etievant C, Baudouin C, Skov K, Charveron M and Hill BT: F 11782, a novel catalytic inhibitor of topoisomerases I and II, induces atypical, yet cytotoxic DNA double-strand breaks in CHO-K1 cells. Anticancer Res 22: 187-92, 2002.
11. Gmeiner WH, Yu S, Pon RT, Pourquier P and Pommier Y: Structural basis for topoisomerase I inhibition by nucleoside analogs. Nucleosides Nucleotides Nucleic Acids 22: 653-658, 2003.
12. Lenardo MJ and Baltimore D: A pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227-229, 1989.
13. Barnes PJ and Gelinas C: Nuclear factor-kappaB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
14. Rayet B and Gélinas C: Aberrant rel/nfkB genes and activity in human cancer. Oncogene 18: 6938-6947, 1999.
15. Cusack JC, Liu R and Baldwin AS: Drug Resistance Updates 2: 271-273, 1999.